| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |